Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Exercise of Options

25 Oct 2013 11:25

RNS Number : 4225R
CVS Group plc
25 October 2013
 

25 October 2013

 

CVS Group plc

("CVS" or the "Company")

 

Exercise of Options

 

CVS, one of the UK's leading providers of veterinary services, announces that, on 24 October 2013, it approved the issue and allotment of 4,977 new ordinary shares of 0.2p each in the Company ("Ordinary Shares") following an exercise of share options by a former CVS employee.

These shares will rank pari passu with all existing Ordinary Shares. Application will be made for admission of these new Ordinary Shares to trading on AIM and dealings are expected to commence on 1 November 2013.

 

 

Contacts:

 

CVS Group plc

Simon Innes, Chief Executive

Nick Perrin, Finance Director

 

Tel: 01379 644 288

 

N+1 Singer - Nominated Adviser & Broker

Aubrey Powell

Alex Wright

 

Tel: 020 7496 3000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOENKPDBKBDDKKB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.